Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1851 |
VCM
Virtue Capital Management
Brentwood,
Tennessee
| $0 | -$207K | 0 | – | Closed |
|
| 1852 |
WIA
Westbourne Investment Advisors
Annapolis,
Maryland
| $0 | -$14K | 0 | – | Closed |
|
| 1853 |
WBC
Westpac Banking Corp
Sydney,
Australia
| $0 | -$4.95M | 0 | – | Closed |
|
| 1854 |
WC
Whitney & Co
Rochester,
New York
| $0 | -$55K | 0 | – | Closed |
|
| 1855 |
WWM
Willingdon Wealth Management
Huntersville,
North Carolina
| $0 | -$91K | 0 | – | Closed |
|
| 1856 |
WAS
Winch Advisory Services
Appleton,
Wisconsin
| $0 | -$3K | 0 | – | Closed |
|
| 1857 |
WCAMG
Woodard & Company Asset Management Group
Bermuda Run,
North Carolina
| $0 | -$16K | 0 | – | Closed |
|
| 1858 |
YMRC
Yorktown Management & Research Company
Forest,
Virginia
| $0 | -$404K | 0 | – | Closed |
|
| 1859 |
ZIG
Zuckerman Investment Group
Chicago,
Illinois
| $0 | -$208K | 0 | – | Closed |
|